Browse > Article
http://dx.doi.org/10.14776/piv.2015.22.3.210

Macrophage Activation Syndrome Triggered by Herpes Viral Infection as the Presenting Manifestation of Juvenile Systemic Lupus Erythematosus  

Noh, Ji Hye (Department of Pediatrics, Yonsei University, Wonju College of Medicine)
Jeong, Do Young (Department of Pediatrics, Yonsei University, Wonju College of Medicine)
Jeon, In Su (Department of Pediatrics, Yonsei University, Wonju College of Medicine)
Kim, Hwang Min (Department of Pediatrics, Yonsei University, Wonju College of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.22, no.3, 2015 , pp. 210-215 More about this Journal
Abstract
Macrophage activation syndrome (MAS) is a rare complication in systemic lupus erythematosus (SLE) that can be triggered by infections. Due to the fact that MAS may mimic clinical features of underlying rheumatic disease, or be confused with an infectious complication, its detection can prove challenging. This is particularly true when there is an unknown/undiagnosed disease; and could turn into an even greater challenge if MAS and SLE are combined with a viral infection. A-14-year-old female came to the hospital with an ongoing fever for 2 weeks and a painful facial skin rash. Hepatomegaly, pancytopenia, increased aspartate aminotransferase, elevated serum ferritin and lactate dehydrogenase were reported. No hemophagocytic infiltration of bone marrow was reported. The patient was suspected for hemophagocytic lymphohistiocytosis. Her skin rashes were eczema herpeticum, which is usually associated with immune compromised conditions. With the history of oral ulcers and malar rash, positive ANA and low C3, C4 and the evidence of hemolytic anemia, she was diagnosed as SLE. According to the diagnostic guideline for MAS in SLE, she was diagnosed MAS as well, activated by acute HSV infection. After administering steroids and antiviral agent, the fever and skin rash disappeared, and the abnormal laboratory findings normalized. Therefore, we are reporting a rare case of MAS triggered by acute HSV infection as the first manifestation of SLE.
Keywords
Macrophage activation syndrome; Herpes viral infection; Systemic lupus erythematosus;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577-87.   DOI
2 Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr 2006;148:683-6.   DOI
3 Shimizu M, Yokoyama T, Tokuhisa Y, Ishikawa S, Sakakibara Y, Ueno K, et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol 2013;146:73-6.   DOI
4 Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60:3388-99.   DOI
5 Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, Bertolaccini L, et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine 2008;87:311-8.   DOI
6 Ueda Y, Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A. Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review. Clin Rheumatol 2014;33:281-6.   DOI
7 Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677-86.   DOI
8 Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008;47:1686-91.   DOI
9 Egues Dubuc CA, Uriarte Ecenarro M, Meneses Villalba C, Aldasoro Caceres V, Hernando Rubio I, Belzunegui Otano J. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus. Reumatol Clin 2014;10:321-4.   DOI
10 Jimenez AT, Vallejo ES, Cruz MZ, Cruz AC, Jara BS. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide. Reumatologia Clinica (English Edition) 2014;10:331-5.   DOI
11 Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 2013;32:899-904.   DOI
12 Stephan J, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology 2001;40:1285-92.   DOI
13 Yeap ST, Sheen JM, Kuo HC, Hwang KP, Yang KD, Yu HR. Macrophage activation syndrome as initial presentation of systemic lupus erythematosus. Pediatr Neonatol 2008;49:39-42.   DOI
14 Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosusassociated hemophagocytic syndrome. Medicine (Baltimore) 2006;85:169-82.   DOI
15 Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.   DOI
16 Hur M, Kim YC, Lee KM, Kim KN. Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis. J Korean Med Sci 2005;20:695-8.   DOI
17 Isome M, Suzuki J, Takahashi A, Murai H, Nozawa R, Suzuki S, et al. Epstein-Barr virus-associated hemophagocytic syndrome in a patient with lupus nephritis. Pediatr Nephrol 2005;20:226-8.   DOI
18 Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8.
19 Benarroch LK, Sterba G, Bosque M. Macrophage activation syndrome (MAS) as a debut of systemic lupus erythematous (SLE) in a child. J Allergy Clin Immunol 2006;117:S210.
20 Shim YS, Kim HS, Kim KN. A case of macrophage activation syndrome successfully treated with combination therapy including etanercept. J Rheum Dis 2012;19:225-9.   DOI
21 Keum SW, Kim MJ, Bae EY, Ham SB, Chung NK, Jeong DC, et al. A case of macrophage activation syndrome developed in female adolescent with systemic lupus erythematosus. J Rheum Dis 2014;21:96-100.   DOI
22 Hwang JY, No SM, Lee J, Jang PS, Kim YH, Kim JT, et al. A case of hemophagocytic lymphohistiocytosis in a child with systemic lupus erythematosus. Korean J Pediatr 2003;46: 1029-31.
23 Kim ES, Kim YG, Kim WS, Jung YS, Han JH, Bae CB, et al. Three cases of secondary hemophagocytic lymphohistiocytosis associated with systemic erythematosus lupus. J Rheum Dis 2015;22:180-5.   DOI